These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33636994)

  • 1. Venlafaxine and desvenlafaxine to be included in the surface water Watch List.
    Lertxundi U; Domingo-Echaburu S; Hernandez R; Medrano J; Orive G
    Aust N Z J Psychiatry; 2021 Nov; 55(11):1112. PubMed ID: 33636994
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of venlafaxine extended release 75  mg and desvenlafaxine 50  mg in healthy CYP2D6 extensive and poor metabolizers: a randomized, open-label, two-period, parallel-group, crossover study.
    Nichols AI; Focht K; Jiang Q; Preskorn SH; Kane CP
    Clin Drug Investig; 2011; 31(3):155-67. PubMed ID: 21288052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of drug efflux protein expression by venlafaxine but not desvenlafaxine.
    Bachmeier CJ; Beaulieu-Abdelahad D; Ganey NJ; Mullan MJ; Levin GM
    Biopharm Drug Dispos; 2011 May; 32(4):233-44. PubMed ID: 21446053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venlafaxine metabolism as a marker of cytochrome P450 enzyme 2D6 metabolizer status.
    Nichols AI; Lobello K; Guico-Pabia CJ; Paul J; Preskorn SH
    J Clin Psychopharmacol; 2009 Aug; 29(4):383-6. PubMed ID: 19593180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome P450 2D6 phenotype predicts antidepressant efficacy of venlafaxine: a secondary analysis of 4 studies in major depressive disorder.
    Lobello KW; Preskorn SH; Guico-Pabia CJ; Jiang Q; Paul J; Nichols AI; Patroneva A; Ninan PT
    J Clin Psychiatry; 2010 Nov; 71(11):1482-7. PubMed ID: 20441720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venlafaxine in human breast milk and nursing infant plasma: determination of exposure.
    Newport DJ; Ritchie JC; Knight BT; Glover BA; Zach EB; Stowe ZN
    J Clin Psychiatry; 2009 Sep; 70(9):1304-10. PubMed ID: 19607765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe acute cardiomyopathy associated with venlafaxine overdose and possible role of CYP2D6 and CYP2C19 polymorphisms.
    Vinetti M; Haufroid V; Capron A; Classen JF; Marchandise S; Hantson P
    Clin Toxicol (Phila); 2011 Nov; 49(9):865-9. PubMed ID: 22077251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of a pharmacokinetic drug-drug interaction with venlafaxine extended-release/indinavir and desvenlafaxine extended-release/indinavir.
    Jann MW; Spratlin V; Momary K; Zhang H; Turner D; Penzak SR; Wright A; VanDenBerg C
    Eur J Clin Pharmacol; 2012 May; 68(5):715-21. PubMed ID: 22173281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of Tako-Tsubo cardiomyopathy in association with ingestion of serotonin/noradrenaline reuptake inhibitors.
    Neil CJ; Chong CR; Nguyen TH; Horowitz JD
    Heart Lung Circ; 2012 Apr; 21(4):203-5. PubMed ID: 22285074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.
    Ball SE; Ahern D; Scatina J; Kao J
    Br J Clin Pharmacol; 1997 Jun; 43(6):619-26. PubMed ID: 9205822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal venlafaxine poisonings are associated with a high prevalence of drug interactions.
    Launiainen T; Rasanen I; Vuori E; Ojanperä I
    Int J Legal Med; 2011 May; 125(3):349-58. PubMed ID: 20432045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin and Norepinephrine Reuptake Inhibitors.
    Shelton RC
    Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential outcomes from metabolic ratios in the identification of CYP2D6 phenotypes--focus on venlafaxine and O-desmethylvenlafaxine.
    Kandasamy M; Srinivas P; Subramaniam K; Ravi S; John J; Shekar R; Srinivas N; Thangam S
    Eur J Clin Pharmacol; 2010 Sep; 66(9):879-87. PubMed ID: 20446083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Desvenlafaxine and neuropathic pain: additional clinical benefits of a second generation serotonin-noradrenaline reuptake inhibitor].
    Alcantara-Montero A
    Rev Neurol; 2017 Mar; 64(5):219-226. PubMed ID: 28229443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venlafaxine.
    Ereshefsky L
    Am Fam Physician; 1997 Nov; 56(8):1964, 1967, 1970. PubMed ID: 9390093
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapid high-performance liquid chromatographic measurement of venlafaxine and O-desmethylvenlafaxine in human plasma. Application to management of acute intoxications.
    Matoga M; Pehourcq F; Titier K; Dumora F; Jarry C
    J Chromatogr B Biomed Sci Appl; 2001 Sep; 760(2):213-8. PubMed ID: 11530979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PharmGKB summary: venlafaxine pathway.
    Sangkuhl K; Stingl JC; Turpeinen M; Altman RB; Klein TE
    Pharmacogenet Genomics; 2014 Jan; 24(1):62-72. PubMed ID: 24128936
    [No Abstract]   [Full Text] [Related]  

  • 18. Serotonin Syndrome Induced by a Single Dose of Venlafaxine and Magnesium Valproate.
    Zhan Z; Cao CS; Huang L
    Psychiatr Danub; 2021; 33(2):193-195. PubMed ID: 34185746
    [No Abstract]   [Full Text] [Related]  

  • 19. Venlafaxine oxidation in vitro is catalysed by CYP2D6.
    Otton SV; Ball SE; Cheung SW; Inaba T; Rudolph RL; Sellers EM
    Br J Clin Pharmacol; 1996 Feb; 41(2):149-56. PubMed ID: 8838442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction of venlafaxine- and duloxetine-induced transaminase elevations with desvenlafaxine in a patient with Gilbert's syndrome.
    Feinberg SS
    CNS Spectr; 2010 Jan; 15(1):53-5. PubMed ID: 20394185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.